09.12.2009 • News

Arch Chemicals Posts Profit

Arch Chemicals posted a surprise quarterly profit as higher pricing and the favorable impact of a recent acquisition offset lower volumes and unfavorable foreign exchange. Net income for the quarter was $3.2 million, or 13 cents a share, compared with $5.7 million, or 23 cents a share, in the same quarter last year. Sales fell 15 % to $293.7 million.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.